The global demand for Computer-Aided Drug Discovery Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Computer-aided drug design (CADD) forms an integral part of the entire process of drug development. It helps to find, develop, and analyze medicines and their associated biological compounds through various computational methods. It aids in the initial stage of the development of chemicals and guides and speeds up the final drug development. So, they help in the clinical trial phases of medicines and the development of drugs for a wide number of diseases.
Market Dynamics
Unlike other sectors, the CADD market witnessed continuous growth during the pandemic because of the methods used to understand the structural aspect of the molecular division of the coronavirus. Various research institutes and biotechnology firms have used these methods to gain more knowledge about the virus so that more and more drugs can be prepared to tackle it. The growth is driven by the rising number of cardiovascular diseases across the world, and after the pandemic, the demand is increased for drugs to treat CVD patients. This will indirectly create demand for the CADD market. However, the lack of skilled labour will be a challenge for growth. The emerging popularity of artificial intelligence and big data will drive the market in the future.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of computer-aided drug discovery. The growth and trends of computer-aided drug discovery industry provide a holistic approach to this study.
Market Segmentation
This section of the computer-aided drug discovery market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- Structure Based Drug Design
- Ligand-Based Drug Design
- Sequence-Based Approaches
By Therapeutic Area
- Oncology
- Neurology
- Cardiovascular Disease
- Respiratory Disease
- Diabetes
- Others
By End User
- Pharmaceutical Companies
- Biotechnology Companies
- Research Laboratories
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Computer-Aided Drug Discovery market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Computer-Aided Drug Discovery Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the computer-aided drug discovery market include BOCSCI Inc., Bioduro-Sundia, Schrödinger, Inc., Aragen Life Sciences Pvt. Ltd., Aris Pharmaceuticals, Inc, Charles River Laboratories, Bayer AG, AstraZeneca, and Albany Molecular Research Inc. (AMRI). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.